Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0.741. It has been cited 20 times, with 14 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.457
From this paper's citation signal
Citation Network Contribution
0.285
From 10 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 14 citers.
NHGRI NIH HHS
Grant: T32 HG009495
NCATS NIH HHS
Grant: TL1 TR001880
National Institutes of Health
Grant: 5T32HG009495-05
Postdoctoral Training Program in Genomic Medicine
National Institutes of Health
Grant: 5TL1TR001880-02
Institutional Clinical and Translational Science Award
National Institutes of Health
Grant: 1K23HL143161-01A1
Impact of the gut microbiome on response to lipid lowering therapy
National Institutes of Health
FWCI
1.39
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals